These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 9422944)

  • 1. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
    Grover R; Ross DA; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma.
    Ramsden AJ; Grover R; Chana J; Tulley P; Sanders R; Wilson GD
    J Plast Reconstr Aesthet Surg; 2007; 60(6):626-30. PubMed ID: 17485049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
    Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of oncogene expression as an independent prognostic marker for primary melanoma.
    Grover R; Pacifico MD; Wilson GD; Sanders R
    Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma.
    Böni R; Bantschapp O; Müller B; Burg G
    Dermatology; 1998; 196(3):288-91. PubMed ID: 9621133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma.
    Ross DA; Wilson GD
    Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.
    Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
    Plast Reconstr Surg; 2005 Feb; 115(2):367-75. PubMed ID: 15692338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular oncogene markers and their significance in cutaneous malignant melanoma.
    Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ
    Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
    Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
    Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic importance of c-myc oncogene expression in head and neck melanoma.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Ann Plast Surg; 2001 Aug; 47(2):172-7. PubMed ID: 11506326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma.
    Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of oncogene expression in subungual melanoma.
    Grover R; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
    Br J Plast Surg; 1997 Jan; 50(1):15-9. PubMed ID: 9038509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
    Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Merkel cell carcinoma: survival and oncogene markers.
    Jemec B; Chana J; Grover R; Grobbelaar AO
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):400-4. PubMed ID: 11305384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer.
    Lipponen PK
    J Pathol; 1995 Feb; 175(2):203-10. PubMed ID: 7738716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.